SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-98-003193
Filing Date
1998-08-28
Accepted
1998-08-28 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH INVEST S.A.BIOTECH TARGET S.A.
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G SC 13G/A 13502
  Complete submission text file 0000950133-98-003193.txt   15519
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 98700034
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000